Skip to main navigation Skip to search Skip to main content

A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study Examining the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/4/17 → 08/3/20

Funding

  • EMD Serono Incorporated: $25,660.00